Entries of von Luettichau, Irene on the publication server

Corbacioglu, Selim , Lode, Holger, Ellinger, Susanne, Zeman, Florian, Suttorp, Meinolf, Escherich, Gabriele, Bochennek, Konrad, Gruhn, Bernd, Lang, Peter, Rohde, Marius, Debatin, Klaus Michael, Steinbach, Daniel, Beilken, Andreas, Ladenstein, Ruth, Spachtholz, Rainer, Heiss, Peter, Hellwig, Dirk , Tröger, Anja, Koller, Michael , Menhart, Karin , Riemenschneider, Markus J. , Zoubaa, Saida, Kietz, Silke, Jakob, Marcus, Sommer, Gunhild , Heise, Tilman , Hundsdörfer, Patrick, Kühnle, Ingrid, Dilloo, Dagmar, Schönberger, Stefan, Schwabe, Georg, von Luettichau, Irene, Graf, Norbert, Schlegel, Paul-Gerhardt, Frühwald, Michael, Jorch, Norbert, Paulussen, Michael, Schneider, Dominik T., Metzler, Markus, Leipold, Alfred, Nathrath, Michaela, Imschweiler, Thomas, Christiansen, Holger, Schmid, Irene, Crazzolara, Roman, Niktoreh, Naghmeh, Cario, Gunnar, Faber, Joerg, Demmert, Martin, Babor, Florian, Fröhlich, Birgit, Bielack, Stefan, Bernig, Toralf, Greil, Johann, Eggert, Angelika, Simon, Thorsten and Foell, Juergen (2024) Irinotecan and temozolomide in combination with dasatinib and rapamycin versus irinotecan and temozolomide for patients with relapsed or refractory neuroblastoma (RIST-rNB-2011): a multicentre, open-label, randomised, controlled, phase 2 trial. The Lancet Oncology 25 (7), pp. 922-932.

Lawitschka, Anita, Brunmair, Matthias, Bauer, Dorothea, Zubarovskaya, Natalia, Felder-Puig, Rosemarie , Strahm, Brigitte, Bader, Peter, Strauss, Gabriele, Albert, Michael, von Luettichau, Irene, Greinix, Hildegard, Wolff, Daniel and Peters, Christina (2021) Psychometric properties of the Activities Scale for Kids-performance after allogeneic hematopoietic stem cell transplantation in adolescents and children. Wiener klinische Wochenschrift 133 (1-2), pp. 41-51. Fulltext not available.

Conrad, Claudius, Hüsemann, Yves, Niess, Hanno, von Luettichau, Irene, Huss, Ralf, Bauer, Christian, Jauch, Karl-Walter, Klein, Christoph A., Bruns, Christiane and Nelson, Peter J. (2011) Linking Transgene Expression of Engineered Mesenchymal Stem Cells and Angiopoietin-1–induced Differentiation to Target Cancer Angiogenesis. Annals of Surgery 253 (3), pp. 566-571. Fulltext not available.